ArticleMovement disorders : official journal of the Movement Disorder Society2026

An Open-Label Phase 1b Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of ANX005 in Patients with Huntington's Disease.

Rajeev Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.